Pelvic Floor Trigger Point Injection With OnabotulinumtoxinA for the Treatment of Severe Myofascial Pelvic Pain (MPP) - A Randomized, Controlled Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02173405

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:40.135536+00:00

Published At

2022-05-10T00:00:00+00:00

Record Updated At

2022-05-10

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Myofascial Pain Syndromes", "Myofascial Trigger Point Pain", "Trigger Point Pain, Myofascial"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2022-05-10"

protocolSection.identificationModule.nctId

"NCT02173405"

protocolSection.identificationModule.officialTitle

"Pelvic Floor Trigger Point Injection With OnabotulinumtoxinA for the Treatment of Severe Myofascial Pelvic Pain (MPP) - A Randomized, Controlled Trial"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Myofascial Pain Syndromes (protocolSection.conditionsModule.conditions)
• Myofascial Trigger Point Pain (protocolSection.conditionsModule.conditions)
• Trigger Point Pain, Myofascial (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.